ASBP Stock Aspire Biopharma Holdings (ASBP, $8.86) soared +57.93% in three months, becoming one of the top quarterly gainers among penny stocks
at Tickeron.com
Loading...
A.I.dvisor analyzed 592 other stocks in the Biotechnology Industry over the last three months, and discovered that of them (6) exhibited an Uptrend while of them (3) exhibited a Downtrend.
ASBP's Stochastic Oscillator dives into oversold zone
The Stochastic Oscillator for ASBP moved into oversold territory on October 01, 2026. Be on the watch for the price uptrend or consolidation in the future. At that time, consider buying the stock or exploring call options.
Technical Analysis (Indicators)
Bullish Trend Analysis
Following a +6.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where ASBP advanced for three days, in 63 of 121 cases, the price rose further within the following month. The odds of a continued upward trend are 52%.
The Aroon Indicator entered an Uptrend today. In 79 of 240 cases where ASBP Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 33%.
Bearish Trend Analysis
The 10-day RSI Indicator for ASBP moved out of overbought territory on September 04, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator moved out of overbought territory. In 12 of the 42 cases, the stock moved lower in the following days. This puts the odds of a move lower at 29%.
The Momentum Indicator moved below the 0 level on September 15, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ASBP as a result. In 38 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 49%.
The Moving Average Convergence Divergence Histogram (MACD) for ASBP turned negative on September 09, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 43 similar instances when the indicator turned negative. In 15 of the 43 cases the stock turned lower in the days that followed. This puts the odds of success at 35%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ASBP declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.
ASBP broke above its upper Bollinger Band on September 02, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 32 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.014) is normal, around the industry mean (6.969). P/E Ratio (0.000) is within average values for comparable stocks, (71.549). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.471). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (28.818) is also within normal values, averaging (49.084).
The Tickeron Price Growth Rating for this company is 65 (best 1 - 100 worst), indicating fairly steady price growth. ASBP’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ASBP’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 88, placing this stock worse than average.